Health insurance benefits of Kadcyla Inj 100mg & 160mg will be registered

Published: 2017-08-07 13:17:12

Updated: 2017-08-07 13:17:12

The health insurance benefits of ‘Kadcyla Inj(trastuzumab emtansine),’ a Roche Korea’s treatment for breast cancer, will be applied today.

The Ministry of Health and Welfare(Minister Neung-Hoo Park) amended and issued the ‘Drug Insurance Benefits List and Upper Limit Price Table’ on the 2^nd.

Volumes of the drug which will be registered in the amendment are Kadcyla Inj 100mg(0.106g/1 bottle) a...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.